Home ยป MKSAP 17 Audio Companion - Rheumatology
MKSAP 17 Audio Companion - Rheumatology
- MKSAP_17_Audio_Companion_Rheumatology.pdf
- 01-01 Introduction to Rheumatology Section.m4a
- 01-02 Approach to the Patient with Rheumatologic Disease.m4a
- 01-03 Inflammatory Versus Noninflammatory Pain.m4a
- 01-04 The Musculoskeletal Examination.m4a
- 01-05 Monoarticular Arthritis and Oligoarthritis.m4a
- 01-06 Polyarthritis.m4a
- 01-07 Question Break 1 A 59-year-old Man is Evaluated for a 6-Month History of Gout.m4a
- 01-08 Dermatologic Manifestations.m4a
- 01-09 Dermatomyositis.m4a
- 01-10 Sarcoidosis and Other Dermatologic Manifestations.m4a
- 01-11 Inflammatory Eye Disease.m4a
- 01-12 Question Break 2 A 71-year-old Man is Evaluated for Severe Tophaceous Gout.m4a
- 01-13 Internal Organ Involvement.m4a
- 01-14 Lung and Kidney Involvement.m4a
- 01-15 GI and Neurologic Involvement.m4a
- 01-16 Rheumatologic and Musculoskeletal Manifestations in Systemic Disease.m4a
- 01-17 Session 1 Key Points.m4a
- 01-18 Close to Session 1.m4a
- 02-01 Introduction to Session 2.m4a
- 02-02 Laboratory Studies.m4a
- 02-03 Complement.m4a
- 02-04 Autoantibody Tests.m4a
- 02-05 Imaging Studies.m4a
- 02-06 Question Break 3 A 21-year-old Woman is Seen for Pain and Swelling of the Wrists, Knees, and Ankles.m4a
- 02-07 Joint Aspiration.m4a
- 02-08 Principles of Therapeutics.m4a
- 02-09 Glucocorticoids.m4a
- 02-10 Colchicine.m4a
- 02-11 Question Break 4 A 32-year-old Woman with Lupus Undergoes a New Patient Evaluation.m4a
- 02-12 Analgesics.m4a
- 02-13 Nonbiologic Disease-Modifying Antirheumatic Drugs.m4a
- 02-14 Methotrexate.m4a
- 02-15 Sulfasalazine and Leflunomide.m4a
- 02-16 Cyclophosphamide.m4a
- 02-17 Mycophenolate Mofetil and Cyclosporine.m4a
- 02-18 Apremilast.m4a
- 02-19 Session 2 Key Points.m4a
- 02-20 Close to Session 2.m4a
- 03-01 Introduction to Session 3.m4a
- 03-02 Biologic Disease-Modifying Antirheumatic Drugs.m4a
- 03-03 Tumor Necrosis Factor Alpha Inhibitors.m4a
- 03-04 Other Biologic Disease-Modifying Antirheumatic Drugs.m4a
- 03-05 Vaccination and Screening in Immunosuppression.m4a
- 03-06 Question Break 5 A 30-year-old Woman is Seen for Increasing Foot Pain.m4a
- 03-07 Urate-Lowering Therapy.m4a
- 03-08 Allopurinol.m4a
- 03-09 Febuxostat.m4a
- 03-10 Probenecid.m4a
- 03-11 Pegloticase.m4a
- 03-12 Rheumatologic Medications and Pregnancy.m4a
- 03-13 Question Break 6 A 52-year-old Man is Seen for Progressively Symptomatic Rheumatoid Arthritis.m4a
- 03-14 Physical and Occupational Therapy.m4a
- 03-15 Complementary and Alternative Medicine.m4a
- 03-16 The Role of Surgery.m4a
- 03-17 Rheumatoid Arthritis.m4a
- 03-18 Pathophysiology and Risk Factors.m4a
- 03-19 Infection and Hormones.m4a
- 03-20 Session 3 Key Points.m4a
- 03-21 Close to Session 3.m4a
- 04-01 Introduction to Session 4.m4a
- 04-02 Diagnosis and Clinical Manifestations.m4a
- 04-03 Laboratory Studies and Imaging Studies.m4a
- 04-04 Complications and Extra-Articular Manifestations.m4a
- 04-05 Question Break 7 A 74-year-old Woman is Seen for Polymyalgia Rheumatica.m4a
- 04-06 Management.m4a
- 04-07 Disease-Modifying Antirheumatic Drugs.m4a
- 04-08 Pregnancy and Rheumatoid Arthritis.m4a
- 04-09 Epidemiology and Pathophysiology of Osteoarthritis.m4a
- 04-10 Risk Factors for OA.m4a
- 04-11 Primary and Erosive Osteoarthritis.m4a
- 04-12 Secondary Osteoarthritis.m4a
- 04-13 Question Break 8 A 25-year-old Woman is Seen for Fatigue and Diffuse Arthralgia.m4a
- 04-14 Diffuse Idiopathic Skeletal Hyperostosis.m4a
- 04-15 Diagnosis of OA.m4a
- 04-16 Differential Diagnosis.m4a
- 04-17 Management.m4a
- 04-18 Pharmacologic Therapy.m4a
- 04-19 Intra-Articular Injection and Glucocorticoid Injection.m4a
- 04-20 Hyaluronic Acid Injection and Surgical Therapy.m4a
- 04-21 Session 4 Key Points.m4a
- 04-22 Close to Session 4.m4a
- 05-01 Introduction to Session 5.m4a
- 05-02 Fibromyalgia.m4a
- 05-03 Diagnosis of Fibromyalgia.m4a
- 05-04 Management.m4a
- 05-05 Spondyloarthritis.m4a
- 05-06 Genetic Factors, Environmental Factors and Classification.m4a
- 05-07 Question Break 9 A 56-year-old Man is Evaluated for Painless Intermittent Bloody Urine.m4a
- 05-08 Ankylosing Spondylitis.m4a
- 05-09 Psoriatic Arthritis.m4a
- 05-10 IBD Associated Arthritis and Reactive Arthritis.m4a
- 05-11 Diagnosis.m4a
- 05-12 Laboratory Studies and Imaging Studies.m4a
- 05-13 General Considerations in Management.m4a
- 05-14 Question Break 10 A 25-year-old Woman is Seen for Increasing Joint Pain and Swelling.m4a
- 05-15 Managing Ankylosing Spondylitis.m4a
- 05-16 Managing Psoriatic Arthritis.m4a
- 05-17 Managing IBD Associated Arthritis and Reactive Arthritis.m4a
- 05-18 Pathophysiology and Epidemiology of Systemic Lupus Erythematosus.m4a
- 05-19 Session 5 Key Points.m4a
- 05-20 Close to Session 5.m4a
- 06-01 Introduction to Session 6.m4a
- 06-02 Mucocutaneous Involvement.m4a
- 06-03 Musculoskeletal Involvement.m4a
- 06-04 Kidney Involvement.m4a
- 06-05 Neuropsychiatric Involvement.m4a
- 06-06 Cardiovascular and Pulmonary Involvement.m4a
- 06-07 Question Break 11 A 65-year-old Man is Seen for Severe Abdominal Pain, Joint Pain, and a Rash.m4a
- 06-08 Hematologic and Gastrointestinal Involvement.m4a
- 06-09 Malignancy.m4a
- 06-10 Diagnosis.m4a
- 06-11 Laboratory Studies.m4a
- 06-12 Drug-Induced Lupus Erythematosus.m4a
- 06-13 Undifferentiated Connective Tissue Disease.m4a
- 06-14 Question Break 12 A 32-year-old Woman is Evaluated for a New Rash on Her Legs.m4a
- 06-15 Managing Lupus.m4a
- 06-16 Hydroxychloroquine and Glucocorticoids.m4a
- 06-17 Pregnancy and Childbirth Issues.m4a
- 06-18 Prognosis.m4a
- 06-19 Session 6 Key Points.m4a
- 06-20 Close to Session 6.m4a
- 07-01 Introduction to Session 7.m4a
- 07-02 Sjogren Syndrome.m4a
- 07-03 Diagnosis of Sjogren Syndrome.m4a
- 07-04 Management.m4a
- 07-05 Prognosis.m4a
- 07-06 Mixed Connective Tissue Disease.m4a
- 07-07 Management.m4a
- 07-08 Crystal Arthropathies.m4a
- 07-09 Pathophysiology.m4a
- 07-10 Causes of Hyperuricemia.m4a
- 07-11 Acute Gouty Arthritis.m4a
- 07-12 Intercritical Gout, Chronic Recurrent and Tophaceous Gout.m4a
- 07-13 Differential Diagnosis of Acute Gouty Arthritis.m4a
- 07-14 Criteria for the Classification of Acute Arthritis of Primary Gout.m4a
- 07-15 Treatment of Acute Gouty Arthritis.m4a
- 07-16 Urate-Lowering Therapy and Prophylaxis.m4a
- 07-17 Calcium Pyrophosphate Deposition.m4a
- 07-18 Cartilage Calcification.m4a
- 07-19 Acute Calcium Pyrophosphate Crystal Arthritis and Pyrophosphate Arthropathy.m4a
- 07-20 Management.m4a
- 07-21 Basic Calcium Phosphate Deposition.m4a
- 07-22 Infectious Arthritis.m4a
- 07-23 Diagnosis.m4a
- 07-24 Clinical Manifestations, Lab Studies and Imaging.m4a
- 07-25 Infection with Gram-Positive Organisms.m4a
- 07-26 Infection with Gram-Negative Organisms.m4a
- 07-27 Session 7 Key Points.m4a
- 07-28 Close to Session 7.m4a
- 08-01 Introduction to Session 8.m4a
- 08-02 Lyme Arthritis.m4a
- 08-03 MycobacteriumTuberculosis and Mycobacterium Marinum.m4a
- 08-04 Fungal Infections.m4a
- 08-05 Viral Infections.m4a
- 08-06 Parvovirus B19.m4a
- 08-07 Rubella and Chikungunya.m4a
- 08-08 Prosthetic Joint Infections.m4a
- 08-09 Management of Infectious Arthritis.m4a
- 08-10 Surgical Therapy.m4a
- 08-11 Idiopathic Inflammatory Myopathies.m4a
- 08-12 Clinical Manifestations.m4a
- 08-13 Muscular Involvement.m4a
- 08-14 Cutaneous Involvement.m4a
- 08-15 Cardiopulmonary and Gastrointestinal Involvement.m4a
- 08-16 Association with Malignancy.m4a
- 08-17 Diagnosis.m4a
- 08-18 Muscle-Related Enzymes.m4a
- 08-19 Autoantibodies.m4a
- 08-20 Imaging Studies and Electromyography.m4a
- 08-21 Muscle Biopsy.m4a
- 08-22 Differential Diagnosis.m4a
- 08-23 Management.m4a
- 08-24 Prognosis.m4a
- 08-25 Session 8 Key Points.m4a
- 08-26 Close to Session 8.m4a
- 09-01 Introduction to Session 9.m4a
- 09-02 Systemic Vasculitis.m4a
- 09-03 Large-Vessel Vasculitis and Giant Cell Arteritis.m4a
- 09-04 Clinical Manifestations and Diagnosis.m4a
- 09-05 Management.m4a
- 09-06 Polymyalgia Rheumatica.m4a
- 09-07 Takayasu Arteritis.m4a
- 09-08 Polyarteritis Nodosa.m4a
- 09-09 Clinical Manifestations and Diagnosis.m4a
- 09-10 Primary Angiitis of the Central Nervous System.m4a
- 09-11 Kawasaki Disease.m4a
- 09-12 Small-Vessel Vasculitis.m4a
- 09-13 ANCA-Associated Vasculitis.m4a
- 09-14 Granulomatosis with Polyangiitis.m4a
- 09-15 Session 9 Key Points.m4a
- 09-16 Close to Session 9.m4a
- 10-01 Introduction to Session 10.m4a
- 10-02 Microscopic Polyangiitis.m4a
- 10-03 Eosinophilic Granulomatosis with Polyangiitis.m4a
- 10-04 Immune Complex-Mediated Vasculitis.m4a
- 10-05 Cryoglobulinemic Vasculitis.m4a
- 10-06 Henoch-Schonlein Purpura.m4a
- 10-07 Hypersensitivity Vasculitis.m4a
- 10-08 Systemic Sclerosis.m4a
- 10-09 Epidemiology and Classification.m4a
- 10-10 Limited Cutaneous Systemic Sclerosis.m4a
- 10-11 Scleroderma-Like Conditions.m4a
- 10-12 Diagnosis.m4a
- 10-13 Clinical Manifestations and Management.m4a
- 10-14 Musculoskeletal and Vascular Involvement.m4a
- 10-15 Gastrointestinal Involvement.m4a
- 10-16 Kidney Involvement.m4a
- 10-17 Pulmonary Involvement.m4a
- 10-18 Session 10 Key Points.m4a
- 10-19 Close to Session 10.m4a
- 11-01 Introduction to Session 11.m4a
- 11-02 Pulmonary Arterial Hypertension.m4a
- 11-03 Cardiac Involvement.m4a
- 11-04 Pregnancy and Systemic Sclerosis.m4a
- 11-05 Behcet Syndrome.m4a
- 11-06 Relapsing Polychondritis.m4a
- 11-07 Adult-Onset Still Disease.m4a
- 11-08 Autoinflammatory Diseases.m4a
- 11-09 Features of Currently Recognized Autoinflammatory Diseases.m4a
- 11-10 Sarcoidosis.m4a
- 11-11 Ehlers-Danlos Syndrome.m4a
- 11-12 Marfan Syndrome.m4a
- 11-13 Osteogenesis Imperfecta.m4a
- 11-14 IgG4-Related Disease.m4a
- 11-15 Session 11 Key Points.m4a
- 11-16 Close to Rheumatology Section.m4a